Practical Session: Measuring & Demonstrating the Value of Patient Engagement Across the Medicines Life Cycle
Time: 3:40 pm
day: Day One
Details:
Join us in this practical session, where we explore the key elements of the Novartis’ Patient Engagement Impact Measurement Framework and discuss the current methods for capturing the impact of patient engagement (PE) on business, Patient-Focused Drug Development (PFDD), and healthcare.
Key Takeaways:
- Examine the next steps in identifying appropriate KPIs to capture and demonstrate the impact of PE activities on business strategy
- Identify the critical tools, resources, and collaborations needed to apply and integrate the approach effectively
- Address key challenges and critical success factors in tracking PE progress and ensuring sustainability
Join this session to discuss standardizing measurement of PE impact, exchange ideas on how to streamline PE activities, demonstrate the value and impact and drive forward the best practices in PE implementation
